Compete for the Flemingsberg Science Award STARTUP 2025– take your ideas to the next level

Finally, registration for the Flemingsberg Science Award STARTUP 2025 is open. Do you have an exciting business idea that deserves expert testing? Are you ready to take it to the next level? Then this competition is perfect for you. Participate and compete for a prize of 10,000 SEK and three months of membership at Innovation Station – a coworking space, innovation hub, and meeting place in the heart of Campus Flemingsberg. 

“The competition is an opportunity for our students, employees, and residents of Flemingsberg to showcase their innovative ideas. Through our collaboration with Venture Cup, we aim to support and promote entrepreneurship and contribute to the development of our local ecosystem for innovation and growth in Flemingsberg,” says Johnny Högberg, CEO of Flemingsberg Science.

Flemingsberg Science AwardSTARTUP is a sub-competition of the national business plan competition Venture Cup and is aimed at students, employees, and residents of Flemingsberg. By participating in the competition, you get the chance to test your business idea with experienced industry experts. The goal of the competition is to attract innovators from Flemingsberg and help them take the step towards realizing their visions while shaping the future of companies.

Important dates:

March 9th – Last day for guaranteed feedback
March 23rd – Deadline

Read more >
Sign up for the competition here >

A Pitch Workshop for Entrepreneurs and Innovators in Flemingsberg

Earlier this spring, the Flemingsberg Science Foundation hosted a pitch workshop aimed at supporting entrepreneurs and innovators with promising ideas in Flemingsberg to elevate their concepts to the next level. This workshop coincided with our prestigious competition, Flemingsberg Science Award.

NextCell Pharma: A Decade at the Forefront of the Stem Cell Revolution

For the past ten years, NextCell Pharma has been developing cell therapies for autoimmune and inflammatory diseases, operating Sweden's largest stem cell biobank through its subsidiary, Cellaviva, and conducting five clinical trials. They celebrate this milestone by launching their third subsidiary, QVance.

In Flemingsberg, we cure diseases that were previously considered incurable

Earlier this year we hosted the most meaningful ATMP event of the spring, in collaboration with Miltenyi Biotec and the Karolinska ATMP Center, Karolinska University Hospital and Karolinska Institutet. We gathered over 120 participants, all sharing a vision of creating momentum to accelerate access to ATMPs in the Nordics.

Go to Top